NKG2D Initiates Caspase-Mediated CD3ζ Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune Disease
Open Access
- 15 November 2010
- journal article
- Published by The American Association of Immunologists
- Vol. 185 (10), 5732-5742
- https://doi.org/10.4049/jimmunol.1002092
Abstract
Deficiencies of the T cell and NK cell CD3ζ signaling adapter protein in patients with cancer and autoimmune diseases are well documented, but mechanistic explanations are fragmentary. The stimulatory NKG2D receptor on T and NK cells mediates tumor immunity but can also promote local and systemic immune suppression in conditions of persistent NKG2D ligand induction that include cancer and certain autoimmune diseases. In this paper, we provide evidence that establishes a causative link between CD3ζ impairment and chronic NKG2D stimulation due to pathological ligand expression. We describe a mechanism whereby NKG2D signaling in human T and NK cells initiates Fas ligand/Fas-mediated caspase-3/-7 activation and resultant CD3ζ degradation. As a consequence, the functional capacities of the TCR, the low-affinity Fc receptor for IgG, and the NKp30 and NKp46 natural cytotoxicity receptors, which all signal through CD3ζ, are impaired. These findings are extended to ex vivo phenotypes of T and NK cells among tumor-infiltrating lymphocytes and in peripheral blood from patients with juvenile-onset lupus. Collectively, these results indicate that pathological NKG2D ligand expression leads to simultaneous impairment of multiple CD3ζ-dependent receptor functions, thus offering an explanation that may be applicable to CD3ζ deficiencies associated with diverse disease conditions.Keywords
This publication has 79 references indexed in Scilit:
- An integrated view of the regulation of NKG2D ligandsImmunology, 2009
- The Traffic of the NKG2D/Dap10 Receptor Complex during Natural Killer (NK) Cell ActivationPublished by Elsevier BV ,2009
- Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupusThe Journal of Experimental Medicine, 2009
- Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15The Journal of Experimental Medicine, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicityProceedings of the National Academy of Sciences of the United States of America, 2008
- Promiscuity and the single receptor: NKG2DNature Reviews Immunology, 2007
- Reprogramming of CTLs into natural killer–like cells in celiac diseaseThe Journal of Experimental Medicine, 2006
- Searching for significance in TCR–cytoskeleton interactionsImmunology Today, 2000
- Signal transduction by lymphocyte antigen receptorsCell, 1994